专利检索 ap:("Albert Einstein College of Medicine" OR "Adimab, LLC" OR "Mapp Biopharmaceutical, Inc." OR "Board of Regents, The University of Texas System" OR "The Government of the United States, as represented by the Secretary of the Army") AND inv:"Andrew S. Herbert" 第 1 页

1.

发明申请
ANTI-CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS ANTIBODIES, AND METHODS OF THEIR GENERATION AND USE 有权

公开(公告)号：US20230000979A1

公开(公告)日：2023-01-05

申请号：US17829164

申请日：2022-05-31

申请人： Albert Einstein College of Medicine , Adimab, LLC , Mapp Biopharmaceutical, Inc. , Board of Regents, The University of Texas System , The Government of the United States, as represented by the Secretary of the Army

发明人： Zachary A. Bornholdt , Akaash Mishra , Laura M. Walker , Noel T. Pauli , Daniel Maurer , Kartik Chandran , Jens Maximilian Fels , Dafna Abelson , Jason Scott McLellan , Jonathan R. Lai , Ariel Wirchnianski , Olivia Vergnolle , John M. Dye , Andrew S. Herbert

IPC分类号： A61K39/42 , A61K45/06 , A61P31/14 , C07K16/10

摘要： Anti-CCHFV antibodies with neutralizing potency and protective efficacy against CCHFV are provided, as well as methods for their identification, isolation, generation, and methods for their preparation and use are provided.